Craft Health’s CraftMake Platform Gets a Peptide Test Run

Specialty pharmaceutical company PharmaTher Holdings is collaborating with Craft Health Pte. Ltd., a Singapore-based pharmaceutical technology company, to test whether Craft Health’s CraftMake 3D printing platform can produce personalized peptide doses. PharmaTher Holdings announced the partnership on July 29, 2026, two days after launching its Personaliz3D Peptides division. The work will focus on six peptides:…